468 related articles for article (PubMed ID: 2824609)
1. Combined oral/nasal immunization protects mice from Sendai virus infection.
Nedrud JG; Liang XP; Hague N; Lamm ME
J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
[TBL] [Abstract][Full Text] [Related]
3. Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice.
Liang XP; Lamm ME; Nedrud JG
Reg Immunol; 1989; 2(4):244-8. PubMed ID: 2561961
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization with Sendai virus in mice.
Nedrud JG; Liang XP; Lamm ME
Curr Top Microbiol Immunol; 1989; 146():117-22. PubMed ID: 2543541
[TBL] [Abstract][Full Text] [Related]
5. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased.
Nedrud JG; Sigmund N
Reg Immunol; 1990-1991; 3(5):217-22. PubMed ID: 1966580
[TBL] [Abstract][Full Text] [Related]
6. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
[TBL] [Abstract][Full Text] [Related]
7. Transport of serum IgA into murine respiratory secretions and its implications for immunization strategies.
Mazanec MB; Nedrud JG; Liang XP; Lamm ME
J Immunol; 1989 Jun; 142(12):4275-81. PubMed ID: 2542407
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
[TBL] [Abstract][Full Text] [Related]
9. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease.
Hodge LM; Simecka JW
J Infect Dis; 2002 Jul; 186(2):290-4. PubMed ID: 12134269
[TBL] [Abstract][Full Text] [Related]
10. Oral immunization against respiratory viruses in mice.
Nedrud J; Sigmund N; Brunschwig E; Lamm M
Adv Exp Med Biol; 1995; 371B():1595-8. PubMed ID: 7502863
[TBL] [Abstract][Full Text] [Related]
11. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
[TBL] [Abstract][Full Text] [Related]
12. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.
Valosky J; Hishiki H; Zaoutis TE; Coffin SE
Clin Diagn Lab Immunol; 2005 Jan; 12(1):171-9. PubMed ID: 15643003
[TBL] [Abstract][Full Text] [Related]
13. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status.
Jessen RH; Emancipator SN; Jacobs GH; Nedrud JG
Lab Invest; 1992 Sep; 67(3):379-86. PubMed ID: 1328763
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
Vaccine; 1990 Jun; 8(3):243-8. PubMed ID: 2363302
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
Hickey DK; Aldwell FE; Beagley KW
Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
18. Cholera toxin conjugates for intragastric vaccination against herpes simplex virus type 2.
Drew MD; Estrada AE; Underdown BJ; McDermott MR
Reg Immunol; 1992; 4(2):79-85. PubMed ID: 1503890
[TBL] [Abstract][Full Text] [Related]
19. Protection against avian metapneumovirus subtype C in turkeys immunized via the respiratory tract with inactivated virus.
Cha RM; Khatri M; Sharma JM
Vaccine; 2011 Jan; 29(3):459-65. PubMed ID: 21073989
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a temperature-sensitive Sendai virus vaccine in hamsters.
Tagaya M; Mori I; Miyadai T; Kimura Y; Ito H; Nakakuki K
Lab Anim Sci; 1995 Jun; 45(3):233-8. PubMed ID: 7650890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
